236 institutions reported holding RDY for 2026Q1, together 14% of the company, more than the 228 a quarter earlier. Institutions reporting a position: 236 (as of 2026Q1). Shares held by institutions: 120.2M, long US equity positions only, as reported on Form 13F. Reported value: $1.66B, at 2026-03-31 prices, not today's. Top 5 holders: 6.7%, of the whole company, between five filers.

RDYDr. Reddy's Laboratories Limited

HealthcareUSD

$12.22

$11.4052 weeks$15.25

Who owns RDY

236 institutions reported holding RDY for 2026Q1, together 14% of the company, more than the 228 a quarter earlier.

236

Institutions reporting a position · as of 2026Q1 · up from 228 the quarter before

Shares held by institutions: 120.2M
Shares held by institutions · 14% of the company · long US equity positions only, as reported on Form 13F
Reported value: $1.66B
Reported value · at 2026-03-31 prices, not today's
Top 5 holders: 6.7%
Top 5 holders · of the whole company, between five filers

Details›

Reporting quarter2026-03-31: 2026Q1
Quarters on record: 52
New positions: 33
Positions exited: 29
Added to: 94
Reduced: 56
Top 10 holdersof the company: 10.0%

Institutional ownership by quarter, 2013Q2 to 2026Q1
Quarter	Filers	Shares	Reported value
2026Q1	236	120.2M	$1.66B
2025Q4	228	106.4M	$1.49B
2025Q3	223	106.9M	$1.49B
2025Q2	234	107.4M	$1.61B
2025Q1	239	109.7M	$1.46B
2024Q4	241	118.4M	$1.87B
2024Q3	226	23.4M	$1.79B
2024Q2	220	24.1M	$1.84B
2024Q1	229	23.6M	$1.73B
2023Q4	221	23.5M	$1.64B
2023Q3	209	21.8M	$1.46B
2023Q2	191	20.7M	$1.31B
2023Q1	187	19.2M	$1.08B
2022Q4	159	16.4M	$850M
2022Q3	149	16.3M	$856M
2022Q2	145	15.6M	$863M

Largest reported holders, 2026Q1
Holder	Shares	% of company	Value
Robeco Investment Management, Inc.	17.2M	2.1%	$238M
BlackRock Inc.	11.6M	1.4%	$160M
ROYAL BANK OF CANADA	10.0M	1.2%	$138M
MORGAN STANLEY	9.4M	1.1%	$130M
Aikya Investment Management Ltd	8.0M	0.96%	$111M
RENAISSANCE TECHNOLOGIES LLC	7.9M	0.94%	$109M
VANGUARD GROUP INC	5.4M	0.64%	$74M
DIMENSIONAL FUND ADVISORS LP	5.3M	0.64%	$74M
JPMORGAN CHASE & CO	4.4M	0.53%	$59M
STATE STREET CORP	4.0M	0.48%	$56M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…

Drug Manufacturers - Specialty & Generic

Ranks #24 of 28 by Smart Score

Compare peers

ELAN+1.7%

Elanco Animal Health Incorporated

NBIX-1.1%

Neurocrine Biosciences, Inc.

Hims & Hers Health, Inc.

LNTH+4.0%

Lantheus Holdings, Inc.